Mi R - Search Results

1

[A multi-center retrospective study of L-asparaginase-based regimens as first-line treatment in newly diagnosed extranodal NK/T-cell lymphoma].

Yuan F, Wei X, Yin Q, Li Y, Mi R, Ai H, Yang H, Li H, Ge S, Liu Y, Song Y. Yuan F, et al. Among authors: mi r. Zhonghua Xue Ye Xue Za Zhi. 2014 Jul;35(7):614-8. doi: 10.3760/cma.j.issn.0253-2727.2014.07.010. Zhonghua Xue Ye Xue Za Zhi. 2014. PMID: 25052604 Chinese.

2

[Clinical significance of IDH1 and IDH2 mutations in patients with acute myeloid leukemia].

Mi RH, Lu XD, Wei XD, Fan RH, Yin QS, Hu JY, Wang Q, Song YP. Mi RH, et al. Zhonghua Xue Ye Xue Za Zhi. 2011 Sep;32(9):610-3. Zhonghua Xue Ye Xue Za Zhi. 2011. PMID: 22338155 Chinese.

3

[Expression and clinical significance of neuron-specific enolase in multiple myeloma].

Mi RH, Yang HP, Wang Q. Mi RH, et al. Zhonghua Xue Ye Xue Za Zhi. 2012 Dec;33(12):1052-3. Zhonghua Xue Ye Xue Za Zhi. 2012. PMID: 23363803 Chinese. No abstract available.

4

CHAG priming regimen containing of cytarabine, aclacinomycin homoharringtonine and G-CSF for relapsed refractory acute myelogenous leukemia: a modified combination chemotherapeutic combination.

Chen L, Yin Q, Mi R, Wei X. Chen L, et al. Among authors: mi r. Leuk Lymphoma. 2013 Oct;54(10):2291-3. doi: 10.3109/10428194.2013.772295. Epub 2013 Mar 8. Leuk Lymphoma. 2013. PMID: 23369043 No abstract available.

5

[Clinical significance of dynamic monitoring of thymic recent output function in different stages of treatment in patients with diffuse large B-cell lymphoma].

Yin QS, Wei XD, Wang XJ, Mi RH, Lü XD, Wang Q, Zhao HF, Li YF, Song YP. Yin QS, et al. Zhonghua Xue Ye Xue Za Zhi. 2013 Jan;34(1):55-9. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 23597467 Chinese.

6

[Effect of TAK1 gene silencing on the apoptosis of Kasumi-1 cells induced by arsenic trioxide].

Xu JX, Fan RH, Wei XD, Yin QS, Mi RH, Song YP. Xu JX, et al. Zhonghua Xue Ye Xue Za Zhi. 2013 May;34(5):417-20. doi: 10.3760/cma.j.issn.0253-2727.2013.05.009. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 23688753 Chinese.

7

[Detection of NPM1, FLT3 and C-KIT mutations in acute myeloid leukemia and their prognostic analysis].

Li L, Lyu XD, Mi RH, Ding J, Chen L, Wang Q, Yin QS, Hu JY, Fan RH, Wei XD. Li L, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Jun;21(3):601-6. doi: 10.7534/j.issn.1009-2137.2013.03.013. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013. PMID: 23815906 Chinese.

8

Treatment with cyclophosphamide, vindesine, cytarabine, dexamethasone and bleomycin in patients with relapsed/refractory diffuse large B-cell lymphoma.

Li M, Li Y, Yin Q, Mi R, Chen L, Du J, Wei X. Li M, et al. Among authors: mi r. Leuk Lymphoma. 2014 Jul;55(7):1578-83. doi: 10.3109/10428194.2013.848984. Epub 2014 Feb 11. Leuk Lymphoma. 2014. PMID: 24070424

9

[Clinical study of COAD-B regimen in treatment of patients with relapsed/refractory non-Hodgkin lymphoma].

Li MH, Li YF, Yin QS, Mi RH, Chen L, Du JW, Wei XD. Li MH, et al. Zhonghua Xue Ye Xue Za Zhi. 2013 Oct;34(10):857-61. doi: 10.3760/cma.j.issn.0253-2727.2013.10.007. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 24171959 Chinese.

10

[Expression of T-bet mRNA and GATA-3 mRNA in peripheral blood mononuclear cells of patients with diffuse large B cell lymphoma].

Chen L, Yin QS, Wei XD, Li QY, Mi RH, Li YF, Song YP. Chen L, et al. Zhonghua Xue Ye Xue Za Zhi. 2013 Nov;34(11):967-9. doi: 10.3760/cma.j.issn.0253-2727.2013.11.013. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 24294855 Chinese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

383 results

Search Page

Filters